Evidence map›Paper›PMID 11226328›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

T M Reyes, K Lewis, M H Perrin, K S Kunitake, J Vaughan, C A Arias, J B Hogenesch, J Gulyas, J Rivier, W W Vale and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 243 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed, 1 pooled it
23.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 1 synthesis or guideline pooled it, 891 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. RareHeliyon · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

T M ReyesLaboratory of Neuronal Structure and Function, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
K Lewis
M H Perrin
K S Kunitake
J Vaughan
C A Arias
J B Hogenesch
J Gulyas
J Rivier
W W Vale
P E Sawchenko
Salk Institute for Biological Studies · USScripps Research Institute · US

Funding

TARGETED DISRUPTION OF NEUROENDOCRINE GENESP01DK026741 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI FISCHER, WOLFGANG H, RIVIER, JEAN E · 1986 to 2014
$31.6M
NEURAL CIRCUITRY OF CYTOKINE-INDUCED ANOREXIAF32DK010135 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI REYES, TERESA M · 2000 to 2002
$119k
NIDDK NIH HHS DK-10135NIDDK NIH HHS DK-26741NIDDK NIH HHS F32 DK010135NIDDK NIH HHS P01 DK026741
6 · The paper itself

Abstract

Here we describe the cloning and initial characterization of a previously unidentified CRF-related neuropeptide, urocortin II (Ucn II). Searches of the public human genome database identified a region with significant sequence homology to the CRF neuropeptide family. By using homologous primers deduced from the human sequence, a mouse cDNA was isolated from whole brain poly(A)(+) RNA that encodes a predicted 38-aa peptide, structurally related to the other known mammalian family members, CRF and Ucn. Ucn II binds selectively to the type 2 CRF receptor (CRF-R2), with no appreciable activity on CRF-R1. Transcripts encoding Ucn II are expressed in discrete regions of the rodent central nervous system, including stress-related cell groups in the hypothalamus (paraventricular and arcuate nuclei) and brainstem (locus coeruleus). Central administration of 1-10 microg of peptide elicits activational responses (Fos induction) preferentially within a core circuitry subserving autonomic and neuroendocrine regulation, but whose overall pattern does not broadly mimic the CRF-R2 distribution. Behaviorally, central Ucn II attenuates nighttime feeding, with a time course distinct from that seen in response to CRF. In contrast to CRF, however, central Ucn II failed to increase gross motor activity. These findings identify Ucn II as a new member of the CRF family of neuropeptides, which is expressed centrally and binds selectively to CRF-R2. Initial functional studies are consistent with Ucn II involvement in central autonomic and appetitive control, but not in generalized behavioral activation.

Indexed as

Amino Acid SequenceAnimalsBehavior, AnimalCHO CellsCloning, MolecularCorticotropin-Releasing HormoneCRF Receptor, Type 1CricetinaeMaleMolecular Sequence DataPolymerase Chain ReactionProto-Oncogene Proteins c-fosRatsRats, Sprague-DawleyReceptors, Corticotropin-Releasing HormoneRNA, MessengerCorticotropin-Releasing HormoneCRF Receptor, Type 1CRF receptor type 2Proto-Oncogene Proteins c-fosReceptors, Corticotropin-Releasing HormoneRNA, Messengerurocortin 2, mouseUrocortins

Identifiers

PMID11226328
PMCPMC30227
OpenAlexW2095646540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.